Endo Pharmaceuticals has recalled two lots of Robaxin affliction medication civic because the characterization carries the amiss dosage, an bulk that could account an overdose.
The characterization in the recalled lots says booty “two to four tablets four times daily.” The actual dosage, according to Endo’s anamnesis announcement, is two tablets three times daily.
Lot Nos. 216702P1 with an cessation date of September 2020 and 220409P1 with an cessation date of January 2021 are both 100-count bottles of 750mg tablets.
Distributors and retailers should acknowledgment any bottles from these lots to the banker or benefactor of sale. Any distributors or retailers with questions should e-mail [email protected] or alarm 866-391-0620, Monday through Friday, 9 a.m. to 5 p.m., Eastern time.
Endo instructs consumers with the recalled Robaxin to stop application it and acknowledgment it. Alarm 866-391-0620 or e-mail [email protected] for instructions on abiding product. For reimbursement, accelerate affidavit of acquirement to [email protected] or via approved mail to Inmar, Attn. Anamnesis Department, Robaxin Recall, 635 Vine St., Winston Salem, NC, 27101.
This isn’t the actual dosage.
PR Newsphoto/Endo International plc
12 Ideas To Organize Your Own Medication Expiration Labels | Medication Expiration Labels – medication expiration labels
| Pleasant to be able to my personal website, in this particular period We’ll explain to you regarding medication expiration labels